BDBM510821 N-(1-(1H-Indol-3-yl)hexan-2- yl)-2-(4-methylpiperazin-1-yl)- 1H-imidazole-5-carboxamide::US11078196, Ex. 9

SMILES CCCCC(Cc1c[nH]c2ccccc12)NC(=O)c1cnc([nH]1)N1CCN(C)CC1

InChI Key InChIKey=QFTWSEWQWZECKW-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 510821   

TargetAlpha-synuclein(Human)
Ucb Biophama

US Patent
LigandPNGBDBM510821(N-(1-(1H-Indol-3-yl)hexan-2- yl)-2-(4-methylpipera...)
Affinity DataIC50: 8.50E+3nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/16/2022
Entry Details
US Patent